Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents

Emerging outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is a major threat to public health. The morbidity is increasing due to lack of SARS-CoV-2 specific drugs. Herein, we have identified potential drugs that target the 3-chymotrypsin like protease (3CLpro), the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mody, Vicky, Ho, Joanna, Wills, Savannah, Mawri, Ahmed, Lawson, Latasha, Ebert, Maximilian C. C. J. C., Fortin, Guillaume M., Rayalam, Srujana, Taval, Shashidharamurthy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817688/
https://www.ncbi.nlm.nih.gov/pubmed/33473151
http://dx.doi.org/10.1038/s42003-020-01577-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817688/
https://www.ncbi.nlm.nih.gov/pubmed/33473151
http://dx.doi.org/10.1038/s42003-020-01577-x

Ejemplares similares